Inventor
TAKAHIRO SUGIMOTO
Inventor
JP
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes19%
G11CStatic stores10%
H10BElectronic memory devices6%
C07BGeneral methods of organic chemistry3%
H01LSemiconductor devices3%
PatentTitleYear
12,421,188Heterocyclic compound and use thereof202512,415,782Heterocyclic compound and use thereof202512,417,793Semiconductor storage device202512,404,237Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives202512,358,879Heterocyclic compound202512,091,410Heterocyclic compound202412,071,434Heterocyclic compound202411,956,951Semiconductor integrated circuit202411,655,241Heterocyclic compound and use thereof202311,440,883Heterocyclic compound and use thereof202211,319,286Heterocyclic compound and application thereof202211,164,639Semiconductor memory device2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to TOSHIBA MEMORY CORP (1)· patent assignee history
2021–2025Based in JP· patent location history
2022–2025Patents assigned to TAKEDA PHARMACEUTICALS CO (9)· patent assignee history
2024–2025Patents assigned to KIOXIA CORP (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 9 | 2022–2025 |
| KIOXIA CORP | 2 | 2024–2025 |
| TOSHIBA MEMORY CORP | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 12 | 2021–2025 |